14h
Zacks Investment Research on MSNSRPT Stock Down After EMA Places Clinical Hold on DMD Gene TherapyShares of Sarepta Therapeutics SRPT dropped more than 6% yesterday after the EMA placed a clinical hold on all studies ...
Given the calls for change, criticism, and ongoing consultations, this article sets out the current status of developments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results